Moreover, MAPK activities can be modulated by deregulated signaling pathways in the early onset of AD, including insulin, Notch, cGMP, and inflammatory ones (Kumphune et al., 2013; Lv et al., 2020; Porcelli et al., 2021; Wei et al., 2021). Here, INS is linked to Alzheimer disease.